LOGIN
Adding Liposomal Bupivacaine to Bupivacaine in Interscalene Blocks in Total Shoulder Arthroplasty
March 2023
Adding Liposomal Bupivacaine to Bupivacaine in Interscalene Blocks in Total Shoulder Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparing bupivacaine alone to liposomal bupivacaine plus bupivacaine in interscalene blocks for total shoulder arthroplasty: a randomized, non-inferiority trial.
Reg Anesth Pain Med. 2023 Jan;48(1): 1-6.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Eighty patients undergoing total shoulder arthroplasty were included in this non-inferiority trial assessing the non-inferiority of bupivacaine (n=40) vs. liposomal bupivacaine plus bupivacaine (n=40) in interscalene brachial plexus block. The primary outcome of interest was 72-hour opioid consumption. Secondary outcomes of interest included opioid consumption, pain scores at rest, during activity...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.